Clinical Outcomes Of Drug-Coated Balloon Angioplasty For Venous In-Stent Restenosis: A Prospective Clinical Study

Localized delivery of antiproliferative medications, such as paclitaxel, can be achieved with DCB therapy, thereby limiting systemic exposure, enhancing venous patency, and improving functional outcomes. Drug-coated stents based on sirolimus can be helpful for patients, underscoring the pharmacological relevance and future scope of this study.